Last updated on June 2019

Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men


Brief description of study

This will be a randomized, multicenter, open-label, active-controlled, efficacy, and safety study in adult hypogonadal men. The study duration is 12 months (365 days), including a 90-day, open-label efficacy period and a 9-month (275-day) safety evaluation period.

Clinical Study Identifier: NCT03198728

Find a site near you

Start Over

Primary Care Research Group

Atlanta, GA United States
  Connect »

Coastal Carolina Research Center

Mount Pleasant, SC United States
  Connect »

Centex Studies, Inc.

Lake Charles, LA United States
  Connect »

Alabama Internal Medicine, P.C.

Birmingham, AL United States
  Connect »

Palm Research Center, Inc.

Las Vegas, NV United States
  Connect »

Meridien Research

Lakeland, FL United States
  Connect »

Aventiv Research, Inc.

Columbus, OH United States
  Connect »

Mid-Columbia Research

Richland, WA United States
  Connect »

Meridien Research

Saint Petersburg, FL United States
  Connect »

Health Awareness, Inc.

Jupiter, FL United States
  Connect »

Centex Studies, Inc.

Houston, TX United States
  Connect »

PAB Clinical Research

Brandon, FL United States
  Connect »

San Diego Sexual Medicine

San Diego, CA United States
  Connect »

Men's Health Boston

Chestnut Hill, MA United States
  Connect »

Advanced Clinical Research

West Jordan, UT United States
  Connect »

Accumed Research Associates

Garden City, NY United States
  Connect »

Advanced Clinical Research

Meridian, ID United States
  Connect »